Please login to the form below
diversity
This page shows the latest diversity news and features for those working in and with pharma, biotech and healthcare.
Janet Woodcock named acting commissioner of the FDA
I also plan to support and promote our commitment to diversity and inclusion, that is such a strength within the agency,” she added.
Latest news
-
Q&A: Shairose Ebrahim
What’s the worst thing about working in healthcare comms? The lack of diversity. ... need more diversity.
-
UK could approve Pfizer’s COVID-19 vaccine this week
For inclusion in the pilot, Pfizer selected Rhode Island, Texas, New Mexico and Tennessee based on the differences in each states’ overall size, diversity of populations and immunisation infrastructures, as well
-
Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today
For inclusion in the pilot, Pfizer selected Rhode Island, Texas, New Mexico and Tennessee based on the differences in each states’ overall size, diversity of populations and immunisation infrastructures, as well
-
Pfizer, BioNTech's COVID-19 vaccine is 95% effective, final analysis shows
For inclusion in the pilot, Pfizer selected Rhode Island, Texas, New Mexico and Tennessee based on the differences in each states’ overall size, diversity of populations and immunisation infrastructures, as well
-
Moderna completes enrolment of phase 3 COVID-19 vaccine trial
The biotech company also touted the diversity of its trial population, with participants from minority groups represented in the overall group.
More from news
Approximately 3 fully matching, plus 134 partially matching documents found.
Latest Intelligence
-
2021: the year of decentralisation in drug development
Improve patient-centricity, trial quality and outcomes with digital health. COVID-19 highlighted the lack of diversity in clinical research, as certain segments of the population, such as older adults, pregnant ... As a result, recently published FDA
-
Is creativity in quarantine?
That requires cross-pollination across businesses and brands; mobilising skilled, collaborative and multi-faceted teams that bring diversity and difference to thinking – and lining everything up with customer needs to develop ... Creativity cannot
-
Leadership and talent
Is a focus on a distinct employee population, in the hope of increasing the diversity of senior talent, the right thing to be investing in right now? ... Increased engagement leads to better performance, both individual and collective. It also provides
-
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country. ... diversity of pharma and biotech companies that sustain activity and help Switzerland maintain its
-
Could formulary intelligence be your brand differentiator?
If you fail to understand – and plan for – the complexity and diversity of the formulary landscape, you will inevitably fall short of commercial expectations in the crucial first year of launch.
More from intelligence
Approximately 2 fully matching, plus 53 partially matching documents found.
Latest appointments
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
In addition, she has a deep understanding of the benefit of cultivating people, diversity and culture to strengthen internal collaboration and propel companies forward.
-
Aurora boosts team with new hires and internal promotions
He has authored Aurora’s reports on collaboration in healthcare, was instrumental to the agency’s award-winning gender diversity work in 2019 and has engaged a wide range of public
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
A champion for science and diversity, Bahija is a highly seasoned pharmaceutical executive with considerable experience in biologics R&D and immuno-oncology.
-
Industry appointments
He added: “The Allergan board has been actively involved in a refreshment process to update its membership with the appropriate experience, talent and diversity to more strongly position Allergan as a
-
Sue Mahony to retire as president of Lilly Oncology
Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest from PMHub
-
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. ... We need to know what motivates or deters them.” Ash Rishi, CEO, Demand Diversity.
-
Mistrust in medical research: a patient perspective
A patient-centric trial design has the knock-on effect of increased recruitment and retention, which can lead to greater diversity and efficiency. ... Overall, the process becomes more relevant to a 21. st. -century diverse population, something that has
-
3 reasons why clinical trials will thrive in 2021
the lack of diversity in clinical trials.
-
The heavy toll of COVID-19 on cancer patients
It also led to a lack of diversity in Black and Hispanic patients.
-
2020 - a year to remember or forget?
But let us not forget the political backdrop with elections, Brexit, a Royal abdication, bushfires, #metoo, Black Lives Matter and a renewed focus on diversity and inclusion, and don’t forget
More from PMHub
Approximately 26 fully matching, plus 42 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- BMS gains FDA approval for second Opdivo combo in kidney cancer
- New study identifies drugs that are safe to use in COVID-19 treatment
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
- Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients
- Moderna’s COVID-19 vaccine appears effective against UK and South Africa variants
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
- Merck ends its COVID-19 vaccine programme after disappointing early trial results
- Wilmington Healthcare appoints new Head of Digital
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- An EU emergency health fund to limit the impact of future crises
- Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
Quick links
Infographics
